Reports for APOTEX INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

257 (7%)

Anticipated shortage:

3 (0%)

Avoided shortage:

11 (0%)

Resolved:

3300 (92%)

3571

Discontinuation Reports

To be discontinued:

24 (7%)

Discontinued:

342 (93%)

Reversed:

0 (0%)

366

143 (4%)

32 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LAMOTRIGINE 100MG TABLET TABLET Resolved 2021-02-12 2021-04-19 133988
APO-LAMOTRIGINE 150MG TABLET Resolved 2023-06-16 2023-06-23 195075
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2024-06-20 2024-06-28 231024
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2020-03-27 2020-05-04 109681
APO-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Resolved 2025-07-25 2025-08-01 263565
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2025-06-19 2025-10-03 260672
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2020-10-14 2020-11-09 126289
APO-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Resolved 2023-02-02 2023-03-16 183480
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2026-01-23 2026-01-23 276565
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2025-11-27 2025-12-20 272623
APO-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Resolved 2022-09-09 2022-10-14 169048
APO-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Resolved 2023-10-20 2023-11-06 207716
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-07-07 2023-09-15 197879
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-05-06 2023-05-26 191877
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2019-06-12 2019-08-19 86282
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2019-05-15 2019-08-19 84125
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2024-04-19 2024-05-03 225761
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-07-13 2023-11-06 198525
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2020-06-04 2020-09-01 116539
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-05-19 2023-06-09 192796
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497
APO-FENTANYL MATRIX 100MCG PATCH Discontinued 2018-02-23 2018-12-28 40741
APO-FENTANYL MATRIX 25MCG PATCH Discontinued 2018-09-07 2018-09-15 60489
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-FLUVOXAMINE TABLETS 50MG TABLET Discontinued 2017-03-30 2018-02-05 4716
APO-FLUVOXAMINE TABLETS 100MG TABLET Discontinued 2017-03-30 2018-02-05 4713
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2019-01-02 2019-01-02 70815
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2018-02-26 2018-02-26 40997
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110965
APO-HYDROMORPHONE CR 30MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110971